SCHEMBL21044477

SCHEMBL21044477

C#Cc1cncc(-c2ccc(N)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.42
CYP11B2 P19099 3/20 0.42
FYN P06241 2/20 0.40
METAP2 P50579 1/20 0.38
ASIC3 Q9UHC3 1/20 0.38
PRKCZ Q05513 2/20 0.38
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
ALDH1A1 P00352 5/20 0.37
MAPT P10636 4/20 0.37
HPGD P15428 4/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 3/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
TP53 P04637 3/20 0.35
CYP3A4 P08684 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21044154 0.82 CYP11B2 (0.56) CYP11B1CYP11B2FYNMETAP2PRKCZ
SCHEMBL30461137 0.80 FYN (0.49) CYP11B2FYNMETAP2ASIC3PRKCZ
SCHEMBL21044251 0.77 FYN (0.40) CYP11B1CYP11B2FYNMETAP2ASIC3
SCHEMBL22869135 0.76 FYN (0.39) CYP11B1CYP11B2FYNMETAP2ASIC3
SCHEMBL4569744 0.76 CDK5 (0.46) CYP11B1CYP11B2PIM3
SCHEMBL2637819 0.72 ATR (0.43)
SCHEMBL23121272 0.72 FYN (0.47) FYNMETAP2PRKCZMEN1KMT2A
SCHEMBL21044502 0.72 CYP11B2 (0.49) CYP11B1CYP11B2FYNMETAP2ASIC3
SCHEMBL25524135 0.72 CYP11B1 (0.47) CYP11B1CYP11B2FYNMETAP2ASIC3
SCHEMBL21121975 0.71 HDAC8 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3717459-B1 COMPOUNDS STEP PHARMA S A S (FR) 2026-01-21 EP disclosed
US-12503466-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2025-12-23 US disclosed
US-20240010645-A1 Aminothiazole Compounds as Inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2024-01-11 US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 US disclosed
US-20210002269-A1 COMPOUNDS STEP PHARMA S.A.S. (FR) 2021-01-07 US disclosed
US-20210002269-A1 COMPOUNDS STEP PHARMA S.A.S. (FR) 2021-01-07 US disclosed
EP-3717459-A1 COMPOUNDS Step Pharma S.A.S. (FR) 2020-10-07 EP disclosed
EP-3492454-A1 COMPOUNDS Step Pharma S.A.S. (FR) 2019-06-05 EP disclosed
EP-3492454-A1 COMPOUNDS Step Pharma S.A.S. (FR) 2019-06-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12503466-B2 Aminothiazole compounds as inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 CYP11B1 1418/4885CYP11B2 1869/4885FYN 4874/4885
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 CYP11B1 1418/4885CYP11B2 1869/4885FYN 4874/4885
US-20210002269-A1 COMPOUNDS UGT1A1, CYP1A1, CYP19A1 CYP11B1 5/4885CYP11B2 6/4885FYN 3915/4885
US-20240010645-A1 Aminothiazole Compounds as Inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 CYP11B1 1418/4885CYP11B2 1869/4885FYN 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.